# Efficacy and Safety of Oxaliplatin Combined With Capecitabine as Neoadjuvant Chemotherapy for Locally Advanced Colon Cancer Patients

> **NCT02415829** · PHASE2 · UNKNOWN · sponsor: **Fudan University** · enrollment: 55 (estimated)

## Conditions studied

- Colorectal Cancer

## Interventions

- **DRUG:** capecitabine plus oxaliplatin

## Key facts

- **NCT ID:** NCT02415829
- **Lead sponsor:** Fudan University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-11
- **Primary completion:** 2016-01
- **Final completion:** —
- **Target enrollment:** 55 (ESTIMATED)
- **Last updated:** 2015-04-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02415829

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02415829, "Efficacy and Safety of Oxaliplatin Combined With Capecitabine as Neoadjuvant Chemotherapy for Locally Advanced Colon Cancer Patients". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02415829. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*